News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 218
- Sources here
- 21
- Companies here
- 6
Active search
218 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
US mining CEO warns key mineral is critical to military as Trump pushes to break China dependence
U.S. Antimony Corporation Chairman and CEO Gary Evans highlights the critical role of specific minerals for military applications and national security. He emphasizes the need to boost domestic production of these critical minerals to reduce American reliance on Chinese rare earth reserves. The discussion …
United States Antimony Corporation CEO to be Featured on Bloomberg Television
The CEO of United States Antimony Corporation (USAC), Mr. Gary C. Evans, is scheduled to be featured live on Bloomberg Television on Monday, August 10, 2026, at approximately 2:30 PM Eastern Time. USAC is a leading producer and processor of antimony, zeolite, and other …
US Antimony CEO Interview to Air Live on Bloomberg TV
United States Antimony Corporation (NYSE: UAMY) announced that its Chairman and CEO, Gary C. Evans, will be featured live on Bloomberg Television at approximately 2:40 PM Eastern Time on Monday, August 10, 2026. The company is a prominent producer and processor of antimony, zeolite, …
ETFs Investing in Harmony Gold Mining Co. Ltd. Stocks
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold stocks of Harmony Gold Mining Co. Ltd. The list is sorted by market value and includes details such as weight, issuer, management style, expense ratio, assets under management (AUM), price, and …
Why Harmony Biosciences (HRMY) Is Up 9.0% After Q2 Earnings Surge And Pipeline Progress
Harmony Biosciences reported a significant 9.0% stock increase after its Q2 2026 earnings surged to US$75.43 million, with basic EPS rising to US$1.30. This strong performance, alongside pipeline progress in rare neurological diseases, reinforces the company's near-term outlook and its reliance on WAKIX revenue …
Harmony Biosciences (NASDAQ:HRMY) Upgraded by Wall Street Zen to "Buy" Rating
Wall Street Zen has upgraded Harmony Biosciences (NASDAQ:HRMY) from a "hold" to a "buy" rating. The company recently reported strong quarterly earnings of $1.28 per share, surpassing estimates, with revenue increasing by 30.3% year-over-year to $261.28 million. Institutional investors hold a significant 86.23% of …
United States Antimony Corporation CEO to be Featured on FOX News ~ Mornings with Maria
United States Antimony Corporation (USAC) announced that its Chairman and CEO, Gary C. Evans, will be featured live on FOX News' "Mornings with Maria" on Monday, August 10, 2026, at approximately 7:30 AM Eastern Time. USAC is a leading producer and processor of antimony, …
Harmony Biosciences Holdings (HRMY) Could Be 19% Undervalued On Strong Q2 Earnings
Harmony Biosciences Holdings (HRMY) has shown strong performance following its Q2 2026 earnings, with increased net income and EPS, supported by WAKIX and pipeline updates. The company's share price has gained significantly over the past 90 days, and a valuation narrative suggests it is …
United States Antimony (UAMY) Stock Trades Near Fair Value On Its Huge 3 Year Run
United States Antimony (UAMY) has seen a significant 12x return over the past three years, but its stock now trades near its intrinsic value based on a Discounted Cash Flow (DCF) model. While the DCF analysis suggests it's modestly undervalued, a Price/Sales (P/S) ratio …
Harmony Biosciences (HRMY) Is Up 9.0% After Q2 Earnings Jump And Pipeline Progress - What's Changed
Harmony Biosciences Holdings, Inc. recently reported second-quarter 2026 results showing net income of US$75.43 million, up from US$39.78 million a year earlier, with basic earnings per share from continuing operations rising to US$1.30 from US$0.69. Alongside these stronger earnings, the company reported progress across …
US Antimony CEO's live FOX Business interview set for about 7:30 a.m.
United States Antimony Corporation (NYSE:UAMY) announced that its Chairman and CEO, Gary C. Evans, will be featured live on FOX News's "Mornings with Maria" on Monday, August 10, 2026, at approximately 7:30 a.m. Eastern Time. The company, a leading producer of antimony, zeolite, and …
United States Antimony Corporation (UAMY) Interactive Stock Chart
This page provides an interactive stock chart and recent news for United States Antimony Corporation (UAMY). The stock closed at 6.85, up 10.31%, and was trading at 6.94 in after-hours. Recent news highlights include Q2 earnings approaching, the CEO being featured on FOX News, …
Harmony Biosciences (NASDAQ: HRMY) holder to sell 700,883 shares
VALOR IV PHARMA HOLDINGS LLC, a shareholder of Harmony Biosciences (NASDAQ: HRMY), has filed to sell up to 700,883 shares of common stock. These shares, with an aggregate market value of $26,563,465.70, were originally acquired in 2017 through a private acquisition. The filing also …
Harmony Biosciences Holdings, Inc. Just Recorded A 34% EPS Beat: Here's What Analysts Are Forecasting Next
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) reported a significant 34% EPS beat for its second quarter, with revenue also exceeding expectations. Analysts have revised their future earnings estimates upwards, projecting robust growth in the coming years. Despite these positive revisions, there are concerns regarding the …
United States Antimony (UAMY) Stock Looks Fully Valued Following Its 14x Run
United States Antimony (UAMY) has seen a significant 14x run over the past three years, but valuation checks now suggest it is fully valued. A Discounted Cash Flow (DCF) model indicates the stock is trading close to its intrinsic value, while market-based multiples, particularly …
XENE's Q2 Loss Narrower Than Expected, Sales Nil, Pipeline in Focus
Xenon Pharmaceuticals XENE reported a loss of $1.11 per share in the second quarter of 2026, narrower than the Zacks Consensus Estimate of a loss of $1.16 per share. The company had incurred a loss of $1.07 per share in the year-ago quarter. In …
United States Antimony Corporation Announces Webcast Time Set for Tuesday, August 11, 2026 at 4:15 PM ET to Report on Second Quarter and Six Months Ended June 30, 2026 Financial and Operating Results
United States Antimony Corporation (NYSE:UAMY) announced that it will host a webcast and conference call on Tuesday, August 11, 2026, at 4:15 PM ET to discuss its financial and operating results for the second quarter and six months ended June 30, 2026. The company, …
Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium
Harmony Biosciences will participate in a fireside chat at the Piper Sandler Virtual CNS Symposium on Thursday, August 13, 2026, at 1:30 p.m. ET. A webcast of the event will be available on the investor page of the company's website. Harmony Biosciences focuses on …
United States Antimony Corporation Provides Update on Mining Activities
United States Antimony Corporation (USAC) has provided an update on its mining activities in Alaska, Montana, and Canada, focusing on antimony, gold, tungsten, and zeolite projects. The company is actively exploring and developing sites like Ester Dome and Nolan Creek in Alaska, Stibnite Hill …
Harmony Biosciences management plans Aug. 13 fireside chat webcast
Harmony Biosciences (Nasdaq: HRMY) announced that its management team will participate in a fireside chat at the Piper Sandler Virtual CNS Symposium on Thursday, August 13, 2026, at 1:30 p.m. ET. A live webcast will be accessible via the investor page of the Harmony …
USAC provides Alaska antimony update
United States Antimony Corporation (USAC) is actively exploring and developing its antimony-gold projects in Alaska, focusing on Ester Dome and the newly acquired Nolan Creek. The company aims to identify high-grade stibnite and plans underground mining at Nolan Creek, with ore to be processed …
Analysts Are Bullish on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Beam Therapeutics (BEAM)
Two healthcare stocks, Harmony Biosciences Holdings (HRMY) and Beam Therapeutics (BEAM), have received bullish ratings from analysts. H.C. Wainwright reiterated a Buy rating for Harmony Biosciences with a $55.00 price target, while Beam Therapeutics holds a Strong Buy consensus with a target of $55.00, …
Harmony Biosciences Holdings, Inc. Stock 12‑Month Price Target Cut to $44.7, Implies 26% Upside
Harmony Biosciences Holdings, Inc.'s average 12-month stock price target has been reduced from $45.5 to $44.7 by 10 analysts, with individual forecasts ranging from $28 to $70 per share. This new target suggests a potential upside of approximately 26% based on the August 3rd …